Vascular Endothelial Growth Factor (VEGF)-driven Actin-based Motility Is Mediated by VEGFR2 and Requires Concerted Activation of Stress-activated Protein Kinase 2 (SAPK2/p38) and Geldanamycin-sensitive Phosphorylation of Focal Adhesion Kinase*
暂无分享,去创建一个
Jacques Landry | Johannes Waltenberger | J. Landry | J. Huot | F. Houle | J. Waltenberger | S. Rousseau | Larry Witte | Jacques Huot | Simon Rousseau | François Houle | L. Witte | H. Kotanides | Helen Kotanides
[1] L. Neckers,et al. The benzoquinone ansamycin geldanamycin stimulates proteolytic degradation of focal adhesion kinase. , 1999, Molecular genetics and metabolism.
[2] H. Ueno,et al. Platelet-derived Growth Factor Activates p38 Mitogen-activated Protein Kinase through a Ras-dependent Pathway That Is Important for Actin Reorganization and Cell Migration* , 1999, The Journal of Biological Chemistry.
[3] K. Alitalo,et al. Endothelial receptor tyrosine kinases involved in angiogenesis , 1995, The Journal of cell biology.
[4] J. Landry,et al. HSP27 phosphorylation-mediated resistance against actin fragmentation and cell death induced by oxidative stress. , 1996, Cancer research.
[5] M. Waxham,et al. Interactions of FLT-1 and KDR with phospholipase C gamma: identification of the phosphotyrosine binding sites. , 1997, Biochemical and biophysical research communications.
[6] M. Shibuya,et al. The phosphorylated 1169-tyrosine containing region of flt-1 kinase (VEGFR-1) is a major binding site for PLCgamma. , 1997, Biochemical and biophysical research communications.
[7] V. Hombach,et al. Functional upregulation of the vascular endothelial growth factor receptor KDR by hypoxia. , 1996, Circulation.
[8] M. Carlier,et al. Control of Actin Dynamics in Cell Motility , 2022 .
[9] J. Landry,et al. Regulation of actin filament dynamics by p38 map kinase-mediated phosphorylation of heat shock protein 27. , 1997, Journal of cell science.
[10] G. Martiny-Baron,et al. Vascular endothelial growth factor up-regulates its receptor fms-like tyrosine kinase 1 (FLT-1) and a soluble variant of FLT-1 in human vascular endothelial cells. , 1997, Cancer research.
[11] Shay Soker,et al. Neuropilin-1 Is Expressed by Endothelial and Tumor Cells as an Isoform-Specific Receptor for Vascular Endothelial Growth Factor , 1998, Cell.
[12] Atsushi Namiki,et al. Indirect Angiogenic Cytokines Upregulate VEGF and bFGF Gene Expression in Vascular Smooth Muscle Cells, Whereas Hypoxia Upregulates VEGF Expression Only , 1994 .
[13] J. Johnson,et al. Parvalbumin relaxes frog skeletal muscle when sarcoplasmic reticulum Ca(2+)-ATPase is inhibited. , 1996, The American journal of physiology.
[14] D. Zechner,et al. A Role for the p38 Mitogen-activated Protein Kinase Pathway in Myocardial Cell Growth, Sarcomeric Organization, and Cardiac-specific Gene Expression , 1997, The Journal of cell biology.
[15] G. Breier,et al. The Vascular Endothelial Growth Factor Receptor Flt-1 Mediates Biological Activities , 1996, The Journal of Biological Chemistry.
[16] J. Martial,et al. Activation of mitogen-activated protein kinases by vascular endothelial growth factor and basic fibroblast growth factor in capillary endothelial cells is inhibited by the antiangiogenic factor 16-kDa N-terminal fragment of prolactin. , 1995, Proceedings of the National Academy of Sciences of the United States of America.
[17] D. Thiele,et al. The Sch9 protein kinase regulates Hsp90 chaperone complex signal transduction activity in vivo , 1999, The EMBO journal.
[18] M. Shibuya,et al. A unique signal transduction from FLT tyrosine kinase, a receptor for vascular endothelial growth factor VEGF. , 1995, Oncogene.
[19] L. Neckers,et al. Inhibition of heat shock protein HSP90-pp60v-src heteroprotein complex formation by benzoquinone ansamycins: essential role for stress proteins in oncogenic transformation. , 1994, Proceedings of the National Academy of Sciences of the United States of America.
[20] R. Jove,et al. The hsp90-binding Antibiotic Geldanamycin Decreases Raf Levels and Epidermal Growth Factor Signaling without Disrupting Formation of Signaling Complexes or Reducing the Specific Enzymatic Activity of Raf Kinase* , 1997, The Journal of Biological Chemistry.
[21] F. Marceau,et al. Effects of experimental conditions on the production of interleukin-1α and -1β by human endothelial cells cultured in vitro , 1992 .
[22] A. Guimond,et al. Characterization of 45-kDa/54-kDa HSP27 kinase, a stress-sensitive kinase which may activate the phosphorylation-dependent protective function of mammalian 27-kDa heat-shock protein HSP27. , 1995, European journal of biochemistry.
[23] J. Waltenberger,et al. The Vascular Endothelial Growth Factor Receptor KDR Activates Multiple Signal Transduction Pathways in Porcine Aortic Endothelial Cells* , 1997, The Journal of Biological Chemistry.
[24] C. Nobes,et al. Rho, Rac, and Cdc42 GTPases regulate the assembly of multimolecular focal complexes associated with actin stress fibers, lamellipodia, and filopodia , 1995, Cell.
[25] I. Zachary,et al. Vascular Endothelial Growth Factor Stimulates Tyrosine Phosphorylation and Recruitment to New Focal Adhesions of Focal Adhesion Kinase and Paxillin in Endothelial Cells* , 1997, The Journal of Biological Chemistry.
[26] Roger Fan,et al. Dynamic activation of endothelial nitric oxide synthase by Hsp90 , 1998, Nature.
[27] Zhong-ying Liu,et al. Characterization of Signal Transduction Pathways in Human Bone Marrow Endothelial Cells , 1997 .
[28] Ivar Giaever,et al. Permissive Role of Nitric Oxide in Endothelin-induced Migration of Endothelial Cells* , 1997, The Journal of Biological Chemistry.
[29] C. Turner,et al. Tyrosine kinase activity, cytoskeletal organization, and motility in human vascular endothelial cells. , 1994, Molecular biology of the cell.
[30] V. Hombach,et al. Suramin is a potent inhibitor of vascular endothelial growth factor. A contribution to the molecular basis of its antiangiogenic action. , 1996, Journal of molecular and cellular cardiology.
[31] L. Zhan,et al. The role of p38 MAP kinase in TGF-beta1-induced signal transduction in human neutrophils. , 1998, Biochemical and biophysical research communications.
[32] T. Sasaki,et al. Involvement of Rho p21 small GTP-binding protein and its regulator in the HGF-induced cell motility. , 1994, Oncogene.
[33] Jacques Landry,et al. SAPK2/p38-dependent F-Actin Reorganization Regulates Early Membrane Blebbing during Stress-induced Apoptosis , 1998, The Journal of cell biology.
[34] Timothy A. J. Haystead,et al. The Amino-terminal Domain of Heat Shock Protein 90 (hsp90) That Binds Geldanamycin Is an ATP/ADP Switch Domain That Regulates hsp90 Conformation* , 1997, The Journal of Biological Chemistry.
[35] S. Hanks,et al. Identification of p130Cas as a Mediator of Focal Adhesion Kinase–promoted Cell Migration , 1998, The Journal of cell biology.
[36] K. Burridge,et al. Rho-stimulated contractility drives the formation of stress fibers and focal adhesions , 1996, The Journal of cell biology.
[37] Philip R. Cohen,et al. SB 203580 is a specific inhibitor of a MAP kinase homologue which is stimulated by cellular stresses and interleukin‐1 , 1995, FEBS letters.
[38] J. Waltenberger,et al. VEGF-A induces expression of eNOS and iNOS in endothelial cells via VEGF receptor-2 (KDR). , 1998, Biochemical and biophysical research communications.
[39] D. Hicklin,et al. Inhibition of vascular endothelial growth factor-induced receptor activation with anti-kinase insert domain-containing receptor single-chain antibodies from a phage display library. , 1998, Cancer research.
[40] T. Noda,et al. Flt-1 lacking the tyrosine kinase domain is sufficient for normal development and angiogenesis in mice. , 1998, Proceedings of the National Academy of Sciences of the United States of America.
[41] J. Isner,et al. Vascular endothelial growth factor/vascular permeability factor enhances vascular permeability via nitric oxide and prostacyclin. , 1998, Circulation.
[42] J. Parsons,et al. Inhibition of cell spreading by expression of the C-terminal domain of focal adhesion kinase (FAK) is rescued by coexpression of Src or catalytically inactive FAK: a role for paxillin tyrosine phosphorylation , 1997, Molecular and cellular biology.
[43] H. Lander,et al. Differential Activation of Mitogen-activated Protein Kinases by Nitric Oxide-related Species* , 1996, The Journal of Biological Chemistry.
[44] R. Alexander,et al. p38 Mitogen-activated Protein Kinase Is a Critical Component of the Redox-sensitive Signaling Pathways Activated by Angiotensin II , 1998, The Journal of Biological Chemistry.
[45] Shay Soker,et al. Characterization of Novel Vascular Endothelial Growth Factor (VEGF) Receptors on Tumor Cells That Bind VEGF via Its Exon 7-encoded Domain (*) , 1996, The Journal of Biological Chemistry.
[46] J. Isner,et al. Vascular endothelial growth factor/vascular permeability factor augments nitric oxide release from quiescent rabbit and human vascular endothelium. , 1997, Circulation.
[47] J. Fiddes,et al. The human gene for vascular endothelial growth factor. Multiple protein forms are encoded through alternative exon splicing. , 1991, The Journal of biological chemistry.
[48] Ivar Giaever,et al. Podokinesis in endothelial cell migration: role of nitric oxide. , 1998, American journal of physiology. Cell physiology.
[49] J. Landry,et al. Oxidative stress-induced actin reorganization mediated by the p38 mitogen-activated protein kinase/heat shock protein 27 pathway in vascular endothelial cells. , 1997, Circulation research.
[50] W. Pratt. The role of the hsp90-based chaperone system in signal transduction by nuclear receptors and receptors signaling via MAP kinase. , 1997, Annual review of pharmacology and toxicology.
[51] John C. Lee,et al. Identification of Mitogen-activated Protein (MAP) Kinase-activated Protein Kinase-3, a Novel Substrate of CSBP p38 MAP Kinase (*) , 1996, The Journal of Biological Chemistry.
[52] M. Kitamura,et al. Oxidant stress incites spreading of macrophages via extracellular signal-regulated kinases and p38 mitogen-activated protein kinase. , 1998, Journal of immunology.
[53] A. Huttenlocher,et al. Adhesion in cell migration. , 1995, Current opinion in cell biology.
[54] H. Granger,et al. Nitric Oxide Is an Upstream Signal of Vascular Endothelial Growth Factor-induced Extracellular Signal-regulated Kinase½ Activation in Postcapillary Endothelium* , 1998, The Journal of Biological Chemistry.
[55] K. Burridge,et al. Focal adhesions, contractility, and signaling. , 1996, Annual review of cell and developmental biology.
[56] W. Pratt. The hsp90-based Chaperone System: Involvement in Signal Transduction from a Variety of Hormone and Growth Factor Receptors , 1998, Proceedings of the Society for Experimental Biology and Medicine. Society for Experimental Biology and Medicine.
[57] S. Soker,et al. Tumor Necrosis Factor-α Regulates Expression of Vascular Endothelial Growth Factor Receptor-2 and of Its Co-receptor Neuropilin-1 in Human Vascular Endothelial Cells* , 1998, The Journal of Biological Chemistry.
[58] Janet Rossant,et al. Failure of blood-island formation and vasculogenesis in Flk-1-deficient mice , 1995, Nature.
[59] J. Behlke,et al. Phosphorylation and supramolecular organization of murine small heat shock protein HSP25 abolish its actin polymerization-inhibiting activity. , 1994, The Journal of biological chemistry.
[60] G. Breier,et al. The role of vascular endothelial growth factor in blood vessel formation. , 1996, Trends in cell biology.
[61] J. Landry,et al. Modulation of cellular thermoresistance and actin filament stability accompanies phosphorylation-induced changes in the oligomeric structure of heat shock protein 27 , 1995, Molecular and cellular biology.
[62] R. Heuertz,et al. C-reactive Protein Inhibits Chemotactic Peptide-induced p38 Mitogen-activated Protein Kinase Activity and Human Neutrophil Movement* , 1999, The Journal of Biological Chemistry.
[63] K. Thomas. Vascular Endothelial Growth Factor, a Potent and Selective Angiogenic Agent (*) , 1996, The Journal of Biological Chemistry.
[64] M. Waxham,et al. Interaction of the Flt-1 Tyrosine Kinase Receptor with the p85 Subunit of Phosphatidylinositol 3-Kinase , 1995, The Journal of Biological Chemistry.
[65] Yihai Cao,et al. Placenta growth factor stimulates MAP kinase and mitogenicity but not phospholipase C-γ and migration of endothelial cells expressing Flt 1 , 1998, Oncogene.
[66] Atsushi Namiki,et al. Hypoxia Induces Vascular Endothelial Growth Factor in Cultured Human Endothelial Cells (*) , 1995, The Journal of Biological Chemistry.
[67] P. Jaakkola,et al. Wound reepithelialization activates a growth factor‐responsive enhancer in migrating keratinocytes , 1998, FASEB journal : official publication of the Federation of American Societies for Experimental Biology.
[68] Y. Yazaki,et al. Vascular endothelial growth factor induces activation and subcellular translocation of focal adhesion kinase (p125FAK) in cultured rat cardiac myocytes. , 1999, Circulation research.
[69] J. Rossant,et al. Role of the Flt-1 receptor tyrosine kinase in regulating the assembly of vascular endothelium , 1995, Nature.
[70] P. Boquet,et al. ADP-ribosylation of a small size GTP-binding protein in bovine neutrophils by the C3 exoenzyme of Clostridium botulinum and effect on the cell motility. , 1991, Biochemical and Biophysical Research Communications - BBRC.
[71] Jacques Landry,et al. p38 MAP kinase activation by vascular endothelial growth factor mediates actin reorganization and cell migration in human endothelial cells , 1997, Oncogene.
[72] F. Hartl,et al. In Vivo Function of Hsp90 Is Dependent on ATP Binding and ATP Hydrolysis , 1998, The Journal of cell biology.
[73] M. Shibuya,et al. Different signal transduction properties of KDR and Flt1, two receptors for vascular endothelial growth factor. , 1994, The Journal of biological chemistry.
[74] A. Bridges,et al. A synthetic inhibitor of the mitogen-activated protein kinase cascade. , 1995, Proceedings of the National Academy of Sciences of the United States of America.